TOP

Products
Products

At Gen Re, we believe that information and collaboration are the basis for great innovation.

We leverage the actuarial, medical, and underwriting expertise of our global units with the market-specific knowledge of our regional departments to support your product initiatives.

Our product development support comprises a wide range of services needed by primary insurers, including design of new products, calculation of the respective rates, and development of policy terms and conditions. Post-launch, our portfolio monitoring and experience studies offer additional valuable insights.

Our Products

Card Image

Mortality

Card Image

Longevity

Card Image

Disability

Card Image

Critical Illness/
Dread Disease

Card Image

Health

Card Image

Long Term Care

Our Services

Underwriting

Risk assessment of individual lives is a core strength at Gen Re. We offer services in all areas of risk assessment.

Learn More

Market Research & Surveys

Understand biometric risks – from single portfolios to market-wide surveys.

Learn More

Analytics

Using a wide range of techniques such as random forest, GLMs or neural networks our data scientists get the most of complex data; always in collaborations with our experts from other fields a maximum of insights and interpretability is achieved.

Learn More

Digital Solutions

We help our clients create digital solutions across the insurance value chain.

Learn More

Recent Research

Understanding Breast Cancer in Asia – Awareness and the Importance of Screening
Breast cancer ranks as the most prevalent cancer worldwide, and a staggering 2.3 million women were diagnosed with the illness globally in 2020. Although the prospects of survival in the battle against breast cancer are improving, the financial burden on patients remains significant. CI benefits can assist with managing the expenses.
Wendy Low, Pei Nee Yong, Samuel Lim
Morbidity Trends – The Long-Term Impact of the Pandemic [Video]
Long COVID’s persistent symptoms, varying from fatigue to organ damage, challenge diagnosis and treatment, affecting many post-recovery. Its impact on work capacity raises concerns for the labor market and disability insurance, with evidence of reduced work schedules and increased unemployment.
Sabrina Link
Group Term Life – Results of 2023 U.S. Market Survey
Sharing results of the latest Gen Re Group Term Life Market Survey, which also covers the Accidental Death and Dismemberment industry. Twenty-six carriers participated in this year’s survey that tracked sales, inforce results, lapse rate, and employee-paid data.
Nicole Conti
Individual Disability – Results of 2023 U.S. Market Survey
Sharing results of the latest Gen Re Individual Disability Market Survey. This year’s benchmarking survey covers Non-Cancelable, Guaranteed Renewable, Buy-Sell and Guaranteed Standard Issue product lines for 2022 and 2023. Seventeen carriers participated in the survey representing $5.4 billion of inforce premium.
Lisa Bolduc
Ushering in a New Era of Cystic Fibrosis Management
It has long been thought that cystic fibrosis is a pediatric disorder but has become a chronic disease to be managed into adulthood. A “new era” in cystic fibrosis care has been announced, however concerns are that these striking innovations will not be available or affordable across all markets.
Dr. Chris Ball

Find an Expert in Your Region